Carregant...

Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension

Introduction Despite new treatment options targeted at its three main pathogenic pathways, prognosis of idiopathic pulmonary arterial hypertension has remained dismal, with 3-year survival rates around 70 %. Antiproliferative agents have emerged as a new therapeutic concept. However, they may exert...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Speich, Rudolf, Treder, Ursula, Domenighetti, Guido, Huber, Lars C., Ulrich, Silvia
Format: Artigo
Idioma:Inglês
Publicat: Springer Netherlands 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3984669/
https://ncbi.nlm.nih.gov/pubmed/24287663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-013-9881-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!